Haloperidol lactate
乳酸氟哌啶醇
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameHaloperidol lactate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1967/04/12
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceuticals IncOrtho-Mcneil Pharmaceutical Inc
Active IndicationsN/A
Inactive Indications +[4]